0
Mirati Therapeutics, Inc. has reached its limit for free report views
Work for Mirati Therapeutics, Inc.? Upgrade Your Profile and unlock all your responsibility reports.
Mirati Therapeutics, Inc.
- 201-500 Employees
- Based in San Diego, California
Mirati Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of products targeting oncology. Its clinical stage product candidates include MGCD265, a multi-targeted kinase inhibitor that is in Phase 1b clinical development trials for the treatment of solid tumors indications, including lung, head and neck, and gastric cancers; MGCD516, a kinase inhibitor, which…More
Mirati Therapeutics, Inc.
Most Recent Responsibility Report
Report Locked. Mirati Therapeutics, Inc. has reached its limit for free report views.
Mirati Therapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Mirati Therapeutics, Inc. Sustainability Report, Mirati Therapeutics, Inc. Corporate Social Responsibility Report, Mirati Therapeutics, Inc. CSR Report, Mirati Therapeutics, Inc. Corporate Responsibility, Mirati Therapeutics, Inc. CR Report, Mirati Therapeutics, Inc. Citizenship Report, Mirati Therapeutics, Inc. ESG Report, and Mirati Therapeutics, Inc. Environmental Report online.